Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Idexx Laboratories Allowance for Doubtful Accounts Receivable (Current) increased by 26.5% to $14.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.6%, from $12.70M to $14.30M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 10.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.40M | $6.50M | $5.70M | $7.30M | $8.00M | $8.80M | $8.30M | $9.10M | $9.80M | $10.10M | $9.50M | $10.60M | $12.30M | $12.40M | $12.60M | $12.70M | $12.20M | $11.70M | $11.30M | $14.30M |
| QoQ Change | — | +1.6% | -12.3% | +28.1% | +9.6% | +10.0% | -5.7% | +9.6% | +7.7% | +3.1% | -5.9% | +11.6% | +16.0% | +0.8% | +1.6% | +0.8% | -3.9% | -4.1% | -3.4% | +26.5% |
| YoY Change | — | — | — | — | +25.0% | +35.4% | +45.6% | +24.7% | +22.5% | +14.8% | +14.5% | +16.5% | +25.5% | +22.8% | +32.6% | +19.8% | -0.8% | -5.6% | -10.3% | +12.6% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's allowance for doubtful accounts receivable (current)?
- Idexx Laboratories (IDXX) reported allowance for doubtful accounts receivable (current) of $14.30M in Q1 2026.
- How has Idexx Laboratories's allowance for doubtful accounts receivable (current) changed year-over-year?
- Idexx Laboratories's allowance for doubtful accounts receivable (current) increased by 12.6% year-over-year, from $12.70M to $14.30M.
- What is the long-term trend for Idexx Laboratories's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Idexx Laboratories's allowance for doubtful accounts receivable (current) has grown at a 10.7% compound annual growth rate (CAGR), from $6.80M to $11.30M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.